Chronic Membranous Conjunctivitis

Considerations on the Importance of Genetics in Ophthalmology

“…It then occurred to us that familial cases were not rare. Thus, Oguchi [1937], Bujadoux [1942], Saubermann [1949], Winter and Michler [1953], Georgiades and Argalias [1960] and Cham bers et al [1969] had observed several cases in the same sibship. Goldmann and Hof [1954] had even described 5 cases in two generations ( fig.…”

Considerations on the Importance of Genetics in Ophthalmology

“…It then occurred to us that familial cases were not rare. Thus, Oguchi [1937], Bujadoux [1942], Saubermann [1949], Winter and Michler [1953], Georgiades and Argalias [1960] and Cham bers et al [1969] had observed several cases in the same sibship. Goldmann and Hof [1954] had even described 5 cases in two generations ( fig.…”

Safety and Efficacy of Long‐Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy

“…PLGD-1 is a chronic condition that intermittently or continuously affects multiple systems and is characterised by the formation of fibrin-rich lesions on mucosa throughout the body [5]. These lesions often occur at sites of injury, infection, or surgery where the normal wound-healing process is impaired due to insufficient plasminogen activity [1,6,7]. The most prevalent symptom of PLGD-1 is ligneous conjunctivitis, characterised by the development of woody, inflamed growths on the conjunctival membranes of the eyes [1,[7][8][9][10][11][12][13][14][15][16][17][18].…”

Considerations on the Importance of Genetics in Ophthalmology

“…It then occurred to us that familial cases were not rare. Thus, Oguchi [1937], Bujadoux [1942], Saubermann [1949], Winter and Michler [1953], Georgiades and Argalias [1960] and Cham bers et al [1969] had observed several cases in the same sibship. Goldmann and Hof [1954] had even described 5 cases in two generations ( fig.…”

Safety and Efficacy of Long‐Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy

“…PLGD-1 is a chronic condition that intermittently or continuously affects multiple systems and is characterised by the formation of fibrin-rich lesions on mucosa throughout the body [5]. These lesions often occur at sites of injury, infection, or surgery where the normal wound-healing process is impaired due to insufficient plasminogen activity [1,6,7]. The most prevalent symptom of PLGD-1 is ligneous conjunctivitis, characterised by the development of woody, inflamed growths on the conjunctival membranes of the eyes [1,[7][8][9][10][11][12][13][14][15][16][17][18].…”

Considerations on the Importance of Genetics in Ophthalmology

“…It then occurred to us that familial cases were not rare. Thus, Oguchi [1937], Bujadoux [1942], Saubermann [1949], Winter and Michler [1953], Georgiades and Argalias [1960] and Cham bers et al [1969] had observed several cases in the same sibship. Goldmann and Hof [1954] had even described 5 cases in two generations ( fig.…”

Safety and Efficacy of Long‐Term Treatment of Type 1 Plasminogen Deficient Patients With Intravenous Plasminogen Replacement Therapy

“…PLGD-1 is a chronic condition that intermittently or continuously affects multiple systems and is characterised by the formation of fibrin-rich lesions on mucosa throughout the body [5]. These lesions often occur at sites of injury, infection, or surgery where the normal wound-healing process is impaired due to insufficient plasminogen activity [1,6,7]. The most prevalent symptom of PLGD-1 is ligneous conjunctivitis, characterised by the development of woody, inflamed growths on the conjunctival membranes of the eyes [1,[7][8][9][10][11][12][13][14][15][16][17][18].…”